Median is a disrupter in the area of medical imaging analysis. Find out more about what we are doing and how our technology works.


Sept 7-11, 2024

WCLC 2024

Join us at the World Conference on Lung Cancer (WCLC) in San Diego, CA, from September 7-11, 2024. Visit us at Booth #2601 to discover the latest advancements in eyonisLCS™:


  • [Podcast] – Shaping Results through Imaging: Addressing Variability in Oncology Trials 

    This is an excerpt from our podcast “Shaping Results through Imaging: Addressing Variability in Oncology Trials”.   Listen to full version of the podcast here : Connor Anderson – Project Manager II, Median Technologies: Thank you for joining this podcast. We are going to start the interview by setting the stage. Can you describe the role imaging…

    Read in full


Introducing Median Imaging Lab

Scientific publications

Double reading performance and the impact of adjudication on progression-free survival estimations: Findings from a lung clinical trial

The FDA recommends Blinded Independent Central Review (BICR) with double reads for imaging in clinical trials, but inter-reader variability raises concerns.

Case studies

Accelerating Site Startups Across the Globe for Oncology Clinical Trial Imaging

White papers

Understanding Novel Response Patterns of Immunotherapies

Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.